Publicaciones en colaboración con investigadores/as de Wellcome Trust Sanger Institute (14)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2019

  1. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  2. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

2018

  1. SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Effects of the catalase antioxidant enzyme in vascular calcification and bone demineralization

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 9, Núm. 1, pp. 13-19

2014

  1. The sex-specific associations of the aromatase gene with Alzheimer's disease and its interaction with IL10 in the Epistasis Project

    European Journal of Human Genetics, Vol. 22, Núm. 2, pp. 216-220

2013

  1. Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease

    Neurobiology of Aging, Vol. 34, Núm. 4, pp. 1309.e1-1309.e7

2012

  1. Interaction of insulin and PPAR-α genes in Alzheimer's disease: The Epistasis Project

    Journal of Neural Transmission, Vol. 119, Núm. 4, pp. 473-479

  2. Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis project

    International Journal of Molecular Epidemiology and Genetics, Vol. 3, Núm. 1, pp. 39-47

  3. Transferrin and HFE genes interact in Alzheimer's disease risk: The Epistasis Project

    Neurobiology of Aging, Vol. 33, Núm. 1, pp. 202.e1-202.e13

2010

  1. The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project

    BMC Medical Genetics, Vol. 11, Núm. 1

2009

  1. Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease

    Journal of Neuroinflammation, Vol. 6, pp. 22